Looking at such figures... The savings for investments, R&D or masks by using POET will be dramatic. So is it very fenciful if I am expecting NRE of several billions (not millions) of USD, especially for companies gaining some exclusivity on POET?
Imagine if you then multiply by price/earnings ratios of e.g. 50-80? OMG! Well, I am just dreaming...
Such payments will not arrive every year then, but just to mention that some SP expectations of board members are not that way out of reality!